Publications

Munster P, Aggarwal R, Hong D, Schellens JH, van der Noll R, Specht J, Witteveen PO, Werner TL, Dees EC, Bergsland E, Agarwal N, Kleha JF, Durante M, Adams L, Smith DA, Lampkin TA, Morris SR, Kurzrock R. First-in-Human Phase I Study of GSK2126458, an Oral Pan-Class I Phosphatidylinositol-3-Kinase Inhibitor, in Patients with Advanced Solid Tumor Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research. 2015. PMID: 26603258


Emily Bergsland, MD

Munster P, Aggarwal R, Hong D, Schellens JH, van der Noll R, Specht J, Witteveen PO, Werner TL, Dees EC, Bergsland E, Agarwal N, Kleha JF, Durante M, Adams L, Smith DA, Lampkin TA, Morris SR, Kurzrock R. First-in-Human Phase I Study of GSK2126458, an Oral Pan-Class I Phosphatidylinositol-3-Kinase Inhibitor, in Patients with Advanced Solid Tumor Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research. 2015. PMID: 26603258


Pamela Munster, MD

Garrett GL, He SY, Sabouni N, Daud A, Arron ST. Combined dabrafenib and trametinib therapy in metastatic melanoma and organ transplantation: Case report and review of the literature. JAAD case reports. 2015. PMID: 27051803


Adil Daud, MD

Esposito MT, Zhao L, Fung TK, Rane JK, Wilson A, Martin N, Gil J, Leung AY, Ashworth A, So CW. Synthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors. Nature medicine. 2015. PMID: 26594843


Alan Ashworth, PhD

Li B, Luo X, Deng B, Wang J, McComb DW, Shi Y, Gaensler KM, Tan X, Dunn AL, Kerlin BA, Dong Y. An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo. Nano letters. 2015. PMID: 26529392


Karin Gaensler, MD

Bol GM, Xie M, Raman V. DDX3, a potential target for cancer treatment. Volume 14 Molecular cancer. 2015. PMID: 26541825


Guus Bol, MD, PhD

Tempero M. At Last: Getting Paid to Think! Journal of the National Comprehensive Cancer Network : JNCCN. 2015. PMID: 26553759


Margaret Tempero, MD

Mabray MC, Cohen BA, Villanueva-Meyer JE, Valles FE, Barajas RF, Rubenstein JL, Cha S. Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms. AJR. American journal of roentgenology. 2015. PMID: 26496556


James Rubenstein, MD, PhD

Kurzrock R, Colevas AD, Olszanski A, Akerley W, Arteaga CL, Carson WE, Clark JW, DiPersio JF, Ettinger DS, Morgan RJ, Schwartzberg LS, Venook AP, Gocke CD, Tait J, Stewart FM. NCCN Oncology Research Program's Investigator Steering Committee and NCCN Best Practices Committee Molecular Profiling Surveys. Journal of the National Comprehensive Cancer Network : JNCCN. 2015. PMID: 26553764


Alan Venook, MD

Jiang H, Rugo HS. Human epidermal growth factor receptor 2 positive (HER2+) metastatic breast cancer: how the latest results are improving therapeutic options. Therapeutic advances in medical oncology. 2015. PMID: 26557900


Hope Rugo, MD

Sanlorenzo M, Vujic I, Daud A, Algazi A, Gubens M, Luna SA, Lin K, Quaglino P, Rappersberger K, Ortiz-Urda S. Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression. JAMA dermatology. 2015. PMID: 26222619


Alain Algazi, MD

Moasser MM, Krop IE. The Evolving Landscape of HER2 Targeting in Breast Cancer. JAMA oncology. 2015. PMID: 26204261


Mark Moasser, MD

Sanlorenzo M, Vujic I, Daud A, Algazi A, Gubens M, Luna SA, Lin K, Quaglino P, Rappersberger K, Ortiz-Urda S. Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression. JAMA dermatology. 2015. PMID: 26222619


Adil Daud, MD

Sanlorenzo M, Vujic I, Daud A, Algazi A, Gubens M, Luna SA, Lin K, Quaglino P, Rappersberger K, Ortiz-Urda S. Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression. JAMA dermatology. 2015. PMID: 26222619


Matthew Gubens, MD, MS

Sheikhbahaei S, Ahn SJ, Moriarty E, Kang H, Fakhry C, Subramaniam RM. Intratherapy or Posttherapy FDG PET or FDG PET/CT for Patients With Head and Neck Cancer: A Systematic Review and Meta-analysis of Prognostic Studies. AJR. American journal of roentgenology. 2015. PMID: 26496559


Hyunseok Kang, MD, MPH

Lee JS, Melisko ME, Magbanua MJ, Kablanian AT, Scott JH, Rugo HS, Park JW. Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer. Breast cancer research and treatment. 2015. PMID: 26520840


John Park, MD

Lee JS, Melisko ME, Magbanua MJ, Kablanian AT, Scott JH, Rugo HS, Park JW. Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer. Breast cancer research and treatment. 2015. PMID: 26520840


Hope Rugo, MD

Lee JS, Melisko ME, Magbanua MJ, Kablanian AT, Scott JH, Rugo HS, Park JW. Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer. Breast cancer research and treatment. 2015. PMID: 26520840


Michelle Melisko, MD

Tsai KK, Daud AI. Nivolumab plus ipilimumab in the treatment of advanced melanoma. Journal of hematology & oncology. 2015. PMID: 26518223


Katy Tsai, MD

Tsai KK, Daud AI. Nivolumab plus ipilimumab in the treatment of advanced melanoma. Journal of hematology & oncology. 2015. PMID: 26518223


Adil Daud, MD